CSRC Position Papers Policy – Final Nov 2010 (PDF file for download)
Defining the Clinical and Regulatory Landscape for Cardiogenic Shock
Use of Mobile Technologies in Clinical Trials for Assessment of Cardiovascular Endpoints
Read the June CiPA update from Jennifer Pierson, HESI senior scientific program manager and download the presentation slides and meeting synopsis from our New Advances in the Assessment of Drug-Induced Arrhythmias and the Comprehensive In Vitro Proarrhythmia Assay (CiPA) meeting.
Read the CSRC statement regarding the FDA’s draft guidance.